Christopher Smith is recorded as CEO and Board Member at Neogenomics Inc (NEO). The newest filing on record that lists Christopher Smith as CEO and Board Member at Neogenomics Inc (NEO) is dated April 6, 2026. Neogenomics Inc reported in an 8-K filed January 10, 2025 that Christopher Smith retired as member of the Company's board of directors, effective April 1, 2025. Neogenomics Inc reported in an 8-K filed January 10, 2025 that Christopher Smith retired as Chief Executive Officer, effective April 1, 2025. The proxy statement of Neogenomics Inc reports total compensation of $4,045,937 for Christopher Smith in fiscal 2025, including a base salary of $310,962. Disclosed compensation is on record for 5 fiscal years. Christopher Smith has spoken on 1 earnings call across 1 company, most recently for Neogenomics Inc on April 30, 2024. Neogenomics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Neogenomics Inc includes Chris Smith (CEO and Board Member), Tony Zook (CEO, Chairman and Board Member), Warren Stone (CEO, COO and Board Member) and 7 others.
“On January 10, 2025, NeoGenomics, Inc. (the “Company”) announced that Christopher Smith, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), will retire effective April 1, 2025 and will continue as a special advisor to the Company.”
Neogenomics Inc Form 8-K, filed January 10, 2025
· Read the filing
“On January 10, 2025, NeoGenomics, Inc. (the “Company”) announced that Christopher Smith, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), will retire effective April 1, 2025 and will continue as a special advisor to the Company.”
Neogenomics Inc Form 8-K, filed January 10, 2025
· Read the filing
Christopher Smith on recent calls
“As always, I want to begin with our mission and vision statements because it's what motivates our company and teammates on a daily basis. Our mission at Neo is to save lives by improving patient care.”
